Lilly forecasting strong 2005
675913
Eli Lilly and Co. said its strategy of staying independent and plowing money into research should pay off in 2005, with profits expected to jump 8 percent to 12 percent over 2004 and nine new drugs in advanced human testing.
163628
The automaker predicts better profits in 2005.
380993
The medical-device maker puts in a nice quarter despite its recent recall trouble.
563588
U.S. stocks should maintain their 3 1/2-year highs this week as they ring out 2004, helped by investor interest in large-cap stocks and a steady rebound in beaten-down drug companies.
763900
Caterpillar Inc., the world&#39;s largest maker of heavy equipment, boosted its 2004 revenue outlook Tuesday, citing strong demand.
708387
French advertising group Publicis predicted 2005 would be a year of growth as it posted a 1.5 percent rise in third-quarter sales, slightly above expectations.
392247
Happy New Year, all you investors with an eye for numerology. According to a popular financial folk tale, there's no need to worry much about Federal Reserve policy or corporate earnings growth in 2005. The stock market, and stock mutual funds, will do just fine because they always prosper in years that end with a five.
662174
Pfizer Inc. (PFE.N: Quote, Profile, Research) on Tuesday reaffirmed it expects 2004 earnings to be more than 20 percent above last year, but warned that results in 2005-2007 will be hurt
123182
Eli Lilly & Company also forecast 2007 earnings at the low end of Wall Street estimates.
761129
Will 2005 prove a better year than 2004? Will the ratio of hits show an upward trend? Well-known producers comment!
175923
The advertising market will be stronger in 2005 than previously thought, ad industry experts say.
340304
Over the last year, this stock has been sweet.
12646
The specialty chip maker predicts a lean transition quarter, but it plans a rebound in 2005.
693925
BMW celebrates record sales in Asia last year and forecasts growth of up to 15% in 2005.
105442
Eli Lilly and Co.  on Thursday forecast profit gains next year below its expected 2006 growth and offered few big surprises at a meeting to describe its experimental drugs, sending shares lower.
573112
Eli Lilly and Co.  on Thursday said its third-quarter earnings rose as growing demand for its medicines offset higher spending to market recently approved treatments.
662735
Anheuser-Busch Cos. on Tuesday reaffirmed its outlook for earnings per share growth for both 2004 and 2005. In a presentation to investors and analysts, management said the company expects earnings per share